Naoki Omachi

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations

Kenichi Nishie, Tomoya Kawaguchi, Akihiro Tamiya et al. · Journal of Thoracic Oncology · 2012 · 107 citations

Medicine, Oncology, Pharmacotherapy +12

Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study

Akihiro Tamiya, Motohiro Tamiya, Takashi Nishihara et al. · Anticancer Research · 2017 · 89 citations · Full text

Medicine, Oncology, Pharmacology +16

A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib

Naoki Omachi, Shigeki Shimizu, Tomoya Kawaguchi et al. · Journal of Thoracic Oncology · 2014 · 58 citations · Full text

Medicine, Oncology, Pathology +17

Spinal Cord Infarction after Bronchial Artery Embolization for Hemoptysis: A Nationwide Observational Study in Japan

Hideo Ishikawa, Hiroyuki Ohbe, Naoki Omachi et al. · Radiology · 2021 · 56 citations

Medicine, Internal Medicine, Clinical Epidemiology +10

Impact of metastatic status on the prognosis of EGFR mutation‑positive non‑small cell lung cancer patients treated with first‑generation EGFR‑tyrosine kinase inhibitors

Yoshihiko Taniguchi, Akihiro Tamiya, Kenji Nakahama et al. · Oncology Letters · 2017 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17